These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 9734360

  • 1. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.
    Desterro JM, Rodriguez MS, Hay RT.
    Mol Cell; 1998 Aug; 2(2):233-9. PubMed ID: 9734360
    [Abstract] [Full Text] [Related]

  • 2. Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha.
    Hay RT, Vuillard L, Desterro JM, Rodriguez MS.
    Philos Trans R Soc Lond B Biol Sci; 1999 Sep 29; 354(1389):1601-9. PubMed ID: 10582246
    [Abstract] [Full Text] [Related]

  • 3. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.
    Roff M, Thompson J, Rodriguez MS, Jacque JM, Baleux F, Arenzana-Seisdedos F, Hay RT.
    J Biol Chem; 1996 Mar 29; 271(13):7844-50. PubMed ID: 8631829
    [Abstract] [Full Text] [Related]

  • 4. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.
    Uehara T, Matsuno J, Kaneko M, Nishiya T, Fujimuro M, Yokosawa H, Nomura Y.
    J Biol Chem; 1999 May 28; 274(22):15875-82. PubMed ID: 10336492
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
    Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR.
    J Biol Chem; 1999 Jan 08; 274(2):787-94. PubMed ID: 9873017
    [Abstract] [Full Text] [Related]

  • 6. Heterologous SUMO-2/3-ubiquitin chains optimize IκBα degradation and NF-κB activity.
    Aillet F, Lopitz-Otsoa F, Egaña I, Hjerpe R, Fraser P, Hay RT, Rodriguez MS, Lang V.
    PLoS One; 2012 Jan 08; 7(12):e51672. PubMed ID: 23284737
    [Abstract] [Full Text] [Related]

  • 7. Inducible NF-kappaB activation is permitted by simultaneous degradation of nuclear IkappaBalpha.
    Renard P, Percherancier Y, Kroll M, Thomas D, Virelizier JL, Arenzana-Seisdedos F, Bachelerie F.
    J Biol Chem; 2000 May 19; 275(20):15193-9. PubMed ID: 10809754
    [Abstract] [Full Text] [Related]

  • 8. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
    Mukhopadhyay A, Manna SK, Aggarwal BB.
    J Biol Chem; 2000 Mar 24; 275(12):8549-55. PubMed ID: 10722693
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.
    Rodriguez MS, Wright J, Thompson J, Thomas D, Baleux F, Virelizier JL, Hay RT, Arenzana-Seisdedos F.
    Oncogene; 1996 Jun 06; 12(11):2425-35. PubMed ID: 8649784
    [Abstract] [Full Text] [Related]

  • 11. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
    Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T.
    Genes Dev; 1995 Jul 01; 9(13):1586-97. PubMed ID: 7628694
    [Abstract] [Full Text] [Related]

  • 12. Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required.
    Van Antwerp DJ, Verma IM.
    Mol Cell Biol; 1996 Nov 01; 16(11):6037-45. PubMed ID: 8887633
    [Abstract] [Full Text] [Related]

  • 13. A MEK inhibitor, PD98059 enhances IL-1-induced NF-kappaB activation by the enhanced and sustained degradation of IkappaBalpha.
    Funakoshi M, Tago K, Sonoda Y, Tominaga S, Kasahara T.
    Biochem Biophys Res Commun; 2001 Apr 27; 283(1):248-54. PubMed ID: 11322796
    [Abstract] [Full Text] [Related]

  • 14. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
    Roussel RR, Barchowsky A.
    Arch Biochem Biophys; 2000 May 01; 377(1):204-12. PubMed ID: 10775461
    [Abstract] [Full Text] [Related]

  • 15. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms.
    Li N, Karin M.
    Proc Natl Acad Sci U S A; 1998 Oct 27; 95(22):13012-7. PubMed ID: 9789032
    [Abstract] [Full Text] [Related]

  • 16. In vivo and in vitro recruitment of an IkappaBalpha-ubiquitin ligase to IkappaBalpha phosphorylated by IKK, leading to ubiquitination.
    Suzuki H, Chiba T, Kobayashi M, Takeuchi M, Furuichi K, Tanaka K.
    Biochem Biophys Res Commun; 1999 Mar 05; 256(1):121-6. PubMed ID: 10066434
    [Abstract] [Full Text] [Related]

  • 17. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1.
    Desterro JM, Rodriguez MS, Kemp GD, Hay RT.
    J Biol Chem; 1999 Apr 09; 274(15):10618-24. PubMed ID: 10187858
    [Abstract] [Full Text] [Related]

  • 18. Activation of the ubiquitin proteolytic system in murine acquired immunodeficiency syndrome affects IkappaBalpha turnover.
    Crinelli R, Bianchi M, Gentilini L, Magnani M, Hiscott J.
    Eur J Biochem; 1999 Jul 09; 263(1):202-11. PubMed ID: 10429205
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppressant FK506 activates NF-kappaB through the proteasome-mediated degradation of IkappaBalpha. Requirement for Ikappabalpha n-terminal phosphorylation but not ubiquitination sites.
    Zhang Y, Sun X, Muraoka K, Ikeda A, Miyamoto S, Shimizu H, Yoshioka K, Yamamoto K.
    J Biol Chem; 1999 Dec 03; 274(49):34657-62. PubMed ID: 10574930
    [Abstract] [Full Text] [Related]

  • 20. Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha.
    de Moissac D, Mustapha S, Greenberg AH, Kirshenbaum LA.
    J Biol Chem; 1998 Sep 11; 273(37):23946-51. PubMed ID: 9727009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.